Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02248077

A Prospective, Randomized, Controlled, Multi-Center, Study Evaluating AutoloGel Therapy for Complete Closure of Wagner Grade 1-4 Diabetic Foot Ulcers, Venous Leg Ulcers and Stage II-IV Pressure Ulcers

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Cytomedix · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is designed to demonstrate the outcome of complete ulcer closure of patients with Wagner Grade 1-4 DFUs, VLUs or Stage II-IV PUs using AutoloGel versus Usual and Customary Care (UCC).

Conditions

Interventions

TypeNameDescription
DEVICEAutoloGel
OTHERUsual and Customary Care (UCC)

Timeline

Start date
2014-10-01
Primary completion
2016-10-01
First posted
2014-09-25
Last updated
2016-10-21

Source: ClinicalTrials.gov record NCT02248077. Inclusion in this directory is not an endorsement.

A Prospective, Randomized, Controlled, Multi-Center, Study Evaluating AutoloGel Therapy for Complete Closure of Wagner G (NCT02248077) · Clinical Trials Directory